scispace - formally typeset
K

Katerina C. Nastou

Researcher at National and Kapodistrian University of Athens

Publications -  29
Citations -  3568

Katerina C. Nastou is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Computer science & Peripheral membrane protein. The author has an hindex of 6, co-authored 24 publications receiving 265 citations. Previous affiliations of Katerina C. Nastou include University of Copenhagen.

Papers
More filters
Journal ArticleDOI

The STRING database in 2023: protein–protein association networks and functional enrichment analyses for any sequenced genome of interest

TL;DR: STRING as mentioned in this paper collects and integrates protein-protein interactions, both physical interactions as well as functional associations, from a number of sources: automated text mining of the scientific literature, computational interaction predictions from co-expression, conserved genomic context, databases of interaction experiments and known complexes/pathways from curated sources.
Journal ArticleDOI

Linear B-Cell Epitope Prediction for In Silico Vaccine Design: A Performance Review of Methods Available via Command-Line Interface.

TL;DR: In this article, the current performance and methodology of some of the most widely used linear B-cell epitope predictors which are available via a command-line interface are reviewed, including BcePred, BepiPred, ABCpred, COBEpro, SVMTriP, LBtope, and LBEEP.
Journal ArticleDOI

The amyloid interactome: Exploring protein aggregation.

TL;DR: A detailed protein map of amyloidogenicity is introduced that will aid immensely towards separate intervention strategies, specifically targeting sub-networks of significant nodes, in an attempt to design possible novel therapeutics for aggregation disorders.
Journal ArticleDOI

The Human Plasma Membrane Peripherome: Visualization and Analysis of Interactions

TL;DR: Interaction data with drug molecules show that ~10% of peripheral membrane proteins are targets for approved drugs, suggesting their potential implications in disease.